Ericka Nicole Hering, APRN

Ericka Hering practices at Tgmg Bayshore in Tampa, Florida.

Ericka Hering's NPI, 1447878129, was assigned on July 9, 2020. Ericka Hering holds Florida license 11007948.

Ericka Hering's primary practice is Tgmg Bayshore, at 409 Bayshore Blvd, Tampa, FL 33606-2707. The practice phone is (813) 844-9302.

Ericka Hering's primary practice is Tgmg Bayshore in Tampa, Florida. The medical group on file is Tampa General Medical Group (TGMG). Dmand AI also links Ericka Hering to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ericka Hering practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Ericka Hering's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Ericka Hering is licensed in Florida.

CMS data shows 195 Medicare services from Ericka Hering across 2 procedure codes in 2024, all of them office visits, for 143 Medicare patients. Medicare paid $10,841 for them. Every service was in an office.

CMS counts 143 Medicare patients who saw Ericka Hering in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ericka Hering's median patient age at 54, with 60% women.

In 2024, Ericka Hering wrote 1,117 Medicare Part D claims for 285 patients. 90% of them were for generic drugs. CMS names the drug for 774 of them, across 35 drugs with 11 or more claims each, at $21,271 in total drug cost.

Ericka Hering accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ericka Hering as offering telehealth.

CMS Open Payments shows 2 general payments to Ericka Hering from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $21.